Sales decline 20.64% to Rs 33.29 crore
Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as against net profit of Rs 6.35 crore during the previous quarter ended June 2023. Sales declined 20.64% to Rs 33.29 crore in the quarter ended June 2024 as against Rs 41.95 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales33.2941.95 -21 OPM %3.6314.99 -PBDT1.077.56 -86 PBT-0.376.35 PL NP-0.726.35 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
